53 results
8-K
EX-1.1
ALXO
Alx Oncology Holdings Inc
6 Oct 23
ALX Oncology Announces Pricing of Public Offering
6:06am
of any litigation, if such settlement is effected with the written consent of the Company), insofar as such loss, claim, damage, liability or expense … , or at common law or otherwise (including in settlement of any litigation, if such settlement is effected with the written consent of such Underwriter
424B5
ALXO
Alx Oncology Holdings Inc
6 Oct 23
Prospectus supplement for primary offering
6:05am
may also have the effect of reducing the likelihood of derivative litigation against directors and officers, even though such an action
424B5
adybkzgcblyleqhf
4 Oct 23
Prospectus supplement for primary offering
5:21pm
8-K
EX-10.1
t2hgdofd
31 Oct 22
ALX Oncology Enters $100 Million Loan Facility Agreement with Oxford Finance and Silicon Valley Bank to Support Ongoing Development of Evorpacept
7:30am
S-3
p29yu ns0
25 Mar 22
Shelf registration
4:44pm
8-K
EX-1.1
ay2oypx0iijkkd
17 Dec 21
Entry into a Material Definitive Agreement
4:59pm
424B5
ro8xco4a6o6lw7ag
17 Dec 21
Prospectus supplement for primary offering
4:57pm